In the present study, we assessed the prognostic significance of expression of the EphB2 receptor and ephrin ligands in breast cancer, as a first exploration of the clinical validity of our hypothesis that ephrin ligands determine the pro- and anti-cancer roles of EphB2. This evidence concerns the gene EPHB2 and breast cancer.